These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 8847042

  • 1. Long-term effect of interferon alpha alone or after prednisone withdrawal in chronic hepatitis B. Interim report and review of the literature.
    Gonzalez-Mateos F, Garcia-Monzon C, Garcia-Buey L, Garcia-Sanchez A, Pajares JM, Moreno-Otero R.
    Hepatogastroenterology; 1995; 42(6):893-9. PubMed ID: 8847042
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: outcomes and predictors of response.
    Hope RL, Weltman M, Dingley J, Fiatarone J, Hope AH, Craig PI, Grierson JM, Bilous M, Williams SJ, Farrell GC.
    Med J Aust; 1995 Jan 02; 162(1):8-11. PubMed ID: 7845310
    [Abstract] [Full Text] [Related]

  • 4. Safety and efficacy of interferon alpha-2b following prednisone withdrawal in the treatment of chronic viral hepatitis B. A case-controlled, randomised study.
    Robson SC, Brice E, van Rensburg C, Kannemeyer J, Hift RJ, Kirsch RE.
    S Afr Med J; 1992 Nov 02; 82(5):317-20. PubMed ID: 1448711
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.
    Zavaglia C, Bottelli R, Bellati G, Asti L, Mondazzi L, Iamoni G, Zanetti A, Tanzi E, Fesce E, Gelosa F, Maggi G, Ideo G.
    Ital J Gastroenterol; 1996 Nov 02; 28(6):324-31. PubMed ID: 8891847
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B.
    Niederau C, Heintges T, Lange S, Goldmann G, Niederau CM, Mohr L, Häussinger D.
    N Engl J Med; 1996 May 30; 334(22):1422-7. PubMed ID: 8618580
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E, Högemann B, Gerritzen A, Fischer HP, Wiese M, Kruis W, Malek M, Gugler R, Schmidt G, Huchzermeyer H, Gerlach U, Dengler HJ, Sauerbruch T.
    Hepatogastroenterology; 1998 May 30; 45(24):2282-94. PubMed ID: 9951911
    [Abstract] [Full Text] [Related]

  • 12. Different doses of recombinant alpha interferon in the treatment of chronic hepatitis B patients without antibodies against the human immunodeficiency virus.
    Porres JC, Carreño V, Mora I, Gutiez J, Moreno A, Ramon y Cajal S, Marron JA, Bartolomé J.
    Hepatogastroenterology; 1988 Dec 30; 35(6):300-3. PubMed ID: 3215626
    [Abstract] [Full Text] [Related]

  • 13. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group.
    Perrillo RP, Schiff ER, Davis GL, Bodenheimer HC, Lindsay K, Payne J, Dienstag JL, O'Brien C, Tamburro C, Jacobson IM, Sampliner R, Feit D, Lefkowitch J, Kuhns M, Meschievitz C, Sanghvi B, Albrecht J, Gibas A, Hepatitis Interventional Therapy Group.
    N Engl J Med; 1990 Aug 02; 323(5):295-301. PubMed ID: 2195346
    [Abstract] [Full Text] [Related]

  • 14. [Chronic hepatitis B. Treatment in childhood with alpha-interferon].
    Wirth S, Sokal E, Schaefer E, Pohlenz J, Keller KM.
    Monatsschr Kinderheilkd; 1992 Oct 02; 140(10):775-9. PubMed ID: 1435800
    [Abstract] [Full Text] [Related]

  • 15. [Long term study of the treatment with recombinant alfa 2b interferon in chronic active hepatitis due to B virus in children and adolescents].
    Castañeda Guillot C, Escobar Capote MD, García Bacallao E, Borbolla Bousquets E.
    G E N; 1994 Oct 02; 48(4):219-25. PubMed ID: 7557276
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. alpha-Interferon retreatment of patients with chronic hepatitis C.
    Rabinovitz M, Block G, Finkelstein SD.
    Am J Gastroenterol; 1996 Aug 02; 91(8):1523-6. PubMed ID: 8759654
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic efficacy of sequential and simultaneous treatments with interferon-alpha and lamivudine in children with chronic hepatitis B.
    Akman SA, Okcu SC, Halicioğlu O, Sutcuoglu S, Anil M, Kizilgunesler A, Bakiler AR.
    Pediatr Int; 2007 Dec 02; 49(6):848-52. PubMed ID: 18045284
    [Abstract] [Full Text] [Related]

  • 20. [Treatment of chronic hepatitis B with interferon alpha-2b].
    Baumgarten R, Müller R, Markus R, Hintsche-Kilger B, Fengler JD, Meisel H.
    Gastroenterol J; 1990 Dec 02; 50(3):124-8. PubMed ID: 2288653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.